OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
OTC: DBLVF 24.07%
Top 5 Canadian Mining Stocks This Week: Adex Mining Shines with 171 Percent Gain
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NYSE: FIGS 32.0%
Why Figs Stock Jumped Today
NASDAQ: PSKY 24.52%
Warner Bros Discovery Deal: Why Netflix May Have Still Won
NASDAQ: ACXIF 31.15%
NASDAQ: DBLVF 31.15%
NASDAQ: KORE 31.15%
NASDAQ: FIGS 31.15%
